264 related articles for article (PubMed ID: 11880682)
1. The problem of biological weapons: next steps for the nation.
O'Toole T
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):108-11. PubMed ID: 11880682
[No Abstract] [Full Text] [Related]
2. National leadership in confronting bioterrorism: 1.
Hamre JJ
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):112-5. PubMed ID: 11880683
[No Abstract] [Full Text] [Related]
3. Legal issues surrounding public health emergencies.
Fidler DP
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):79-86. PubMed ID: 11880678
[No Abstract] [Full Text] [Related]
4. Time is running out. Congress' budget inaction considered a threat to bioterrorism preparedness.
Tieman J
Mod Healthc; 2002 Oct; 32(43):10. PubMed ID: 12436770
[No Abstract] [Full Text] [Related]
5. Reducing the bioweapons threat: international collaboration efforts.
Eitzen EM
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):17-8. PubMed ID: 11880663
[No Abstract] [Full Text] [Related]
6. Bioterrorism, public health, and civil liberties.
Annas GJ
N Engl J Med; 2002 Apr; 346(17):1337-42. PubMed ID: 11973377
[No Abstract] [Full Text] [Related]
7. National leadership in confronting bioterrorism: 2.
Kennedy EM
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):116-8. PubMed ID: 11880684
[No Abstract] [Full Text] [Related]
8. National disaster medical system.
Knouss RF
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):49-52. PubMed ID: 11880672
[No Abstract] [Full Text] [Related]
9. Combating bioterrorism with bioengineering.
Laxminarayan S; Kun LG
IEEE Eng Med Biol Mag; 2002; 21(5):21, 23-7. PubMed ID: 12405054
[No Abstract] [Full Text] [Related]
10. Epidemic response scenario: decision making in a time of plague.
O'Toole T; Inglesby TV
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):92-103. PubMed ID: 11880680
[No Abstract] [Full Text] [Related]
11. Observations from the Top Off exercise.
Inglesby TV
Public Health Rep; 2001; 116 Suppl 2(Suppl 2):64-8. PubMed ID: 11880675
[No Abstract] [Full Text] [Related]
12. Biodefense: who's in charge?
Sutton V
Health Matrix Clevel; 2003; 13(1):117-58. PubMed ID: 14569660
[No Abstract] [Full Text] [Related]
13. Legal preparedness for bioterrorism.
Matthews GW; Benjamin G; Mills SP; Parmet W; Misrahi JJ
J Law Med Ethics; 2002; 30(3 Suppl):52-6. PubMed ID: 12508503
[TBL] [Abstract][Full Text] [Related]
14. A shocking biodefense editorial.
Vanderwagen WC
Nat Biotechnol; 2007 Oct; 25(10):1083; author reply 1083-4. PubMed ID: 17921983
[No Abstract] [Full Text] [Related]
15. Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006.
Schuler A
Biosecur Bioterror; 2005; 3(2):94-101. PubMed ID: 16000040
[TBL] [Abstract][Full Text] [Related]
16. US biodefense--shocking and awful.
Nat Biotechnol; 2007 Jun; 25(6):603. PubMed ID: 17557081
[No Abstract] [Full Text] [Related]
17. Pharmaceuticals and the strategic national stockpile program.
Stewart A; Cordell GA
Dent Clin North Am; 2007 Oct; 51(4):857-69, vii. PubMed ID: 17888762
[TBL] [Abstract][Full Text] [Related]
18. Health care's counterterrorism efforts: what's being done and what isn't.
Coates V
Manag Care; 2003 Nov; 12(11 Suppl):19-21. PubMed ID: 14669389
[No Abstract] [Full Text] [Related]
19. Cell therapy and homeland security: funding opportunities for biomedical research.
Marty PJ; Sanberg PR; Daugherty RM
Cell Transplant; 2003; 12(6):553-4. PubMed ID: 14579922
[No Abstract] [Full Text] [Related]
20. The state of biopreparedness: lessons from leaders, proposals for progress.
Franco C; Hansen MB
Biosecur Bioterror; 2010 Dec; 8(4):379-84. PubMed ID: 21142766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
